What You Should Know:
– CIMSS has acquired RxCompli, a medication adherence provider of a personalized caregiver sensor/app that alerts patients to take their medications as prescribed.
– The acquisition offers a new technology platform to physicians that ensures their patients take the right medication at the right time. Financial details of the acquisition were not disclosed.
Non-Adherence of Medication is a Growing Problem in the USA
50% of patients do not take medications as prescribed, resulting in $100 billion of unnecessary spending and 125,000 lives lost each year, according to Duke Health. Therefore, this acquisition will help prolong lives and lower costs for the patient.
How RxCOMPLi Works
Patients take the right medication and at the right time with the help of our sensors, SMART app, and reporting. RxCompli sensors stick on all kinds of containers (Pill Bottle, Pill Box, Inhaler, Injectables). The sensor sends out smart reminders using a combination of LED and buzzer and automatically records medication intakes. It flags overuse and underuse of medications and keeps a tab on medication adherence and alerts for timely refills. Once programmed, the sensor works independently of smartphones with a battery life of nine months.
“With the acquisition of RxCompli, we can offer easily deployable technology to physicians, like the app and cloud integration, so they can be sure that their patients are taking the right medication at the right time,” says Dr. Paramjit “Romi” Chopra, MD and CEO of CIMSS. “Each physician and physician group we work with is at the center of our universe, and we believe in supporting them from beginning to end. By acquiring RxCompli, we can provide them with more support than ever before.”
